Last Week’s Hot Topic on Pulmonary Fibrosis

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

news_pf

Last week’s hot topic on pulmonary fibrosis was OFEV’s Effectiveness as IPF Treatment Confirmed in Analysis of Pooled Clinical Trial Data written by Margarida Azevedo.

This article is about combined evidence from the TOMORROW and INPULSIS clinical trials that confirm the safety and efficacy of OFEV (nintedanib, Boehringer Ingelheim) in slowing disease progression and greatly reducing acute exacerbations in patients with idiopathic pulmonary fibrosis (IPF), a study reported.

The article detailing the pooled analyses of the clinical studies, “Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials,” was published in the journal Respiratory Medicine.

 

Read the latest news on pulmonary fibrosis: http://bit.ly/1lfMsiZ

Print This Page

About the Author

Marta Ribeiro avatar
Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Tags

hot topic, Idiopathic pulmonary fibrosis (IPF), IPF, pulmonary fibrosis

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums

Recent Posts


Recommended reading